Eisler Capital (Us) LLC Bristol Myers Squibb CO Transaction History
Eisler Capital (Us) LLC
- $4.67 Trillion
- Q3 2024
A detailed history of Eisler Capital (Us) LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 6,390 shares of BMY stock, worth $319,883. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,390
Previous 18,010
64.52%
Holding current value
$319,883
Previous $748 Million
55.8%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,788Shares Held
1.57BCall Options Held
27.4MPut Options Held
27.8M-
Vanguard Group Inc Valley Forge, PA191MShares$9.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.94 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.81 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.76 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$3.03 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...